Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion type Assertion NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_head.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion description "[Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_provenance.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion evidence source_evidence_literature NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_provenance.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion SIO_000772 16648505 NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_provenance.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion wasDerivedFrom befree-20140225 NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_provenance.
- NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_assertion wasGeneratedBy ECO_0000203 NP275750.RA09zKZ-3VzyMHrN5pQapNm5OWwteXOTuZWdORWFNYC04130_provenance.